Use in pregnancy: Finasteride is contraindicated in pregnancy because of the ability of Type II 5-alpha reductase inhibitors to inhibit conversion of testosterone to dihydrotestosterone. These drugs, including Finasteride, may cause abnormalities of the external genitalia of a male foetus when administered to a pregnant woman.
Use in Lactation: It is not known if Finasteride is excreted in human milk.
Exposure to Finasteride (by pregnant women) - Risk to Male fetus: Finasteride tablets are film-coated and will prevent contamination with the active ingredient during normal handling, provided that the tablets have not been broken or crushed. Pregnant women should not handle crushed or broken Finasteride tablets because of the possibility of absorption of Finasteride and the subsequent potential risk to male fetus. In addition, since Finasteride is present in semen, male patients should wear condom or otherwise avoid exposure of female sexual partners at risk of becoming pregnant.
Other Services
Country
Account